Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
326.20    -4.40 (-1.33%)
Bid:
325.60
Ask:
326.20
Spread: 0.60 (0.184%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Director/PDMR Shareholding

17 May 2022 11:00

RNS Number : 7745L
Hammerson PLC
17 May 2022
 

Hammerson plc (the "Company")

Notification of Transactions of Directors and PDMRs

17 May 2022

 

The Company has been notified of the following transactions in the Company's ordinary 5 pence shares undertaken by Directors/Persons Discharging Managerial Responsibilities ("PDMRs") and their Persons Closely Associated ("PCAs") pursuant to the Company's Enhanced Scrip Dividend Alternative at GBP 2 pence per share as announced on 4 March 2022 (the "Enhanced Scrip Dividend Alternative").

 

Name

Ordinary Shares acquired pursuant to Enhanced Scrip Dividend Alternative

Méka Brunel

1,373

Adam Metz

49,117

Alan Olivier

43,899

 

This announcement is made in accordance with the requirements of the UK Market Abuse Regulation. The notification of dealing forms can be found below.

 

Emma Jackman

Senior Assistant Company Secretary

+44 (0) 20 7887 1000

 

Notification of dealing form

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Méka Brunel

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer

a)

Name

Hammerson plc

b)

LEI

213800G1C9KKVVDN1A60

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument.

 

 

Identification code

Ordinary 5 pence shares

 

 

 

ISIN: GB00BK7YQK64

b)

Nature of the transaction

Acquisition of ordinary shares of 5 pence pursuant to the Enhanced Scrip Dividend Alternative.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.3176

1,373

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

£0.3176

1,373

£436.06

e)

Date of the transaction

10 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Notification of dealing form

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Adam Metz

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer

a)

Name

Hammerson plc

b)

LEI

213800G1C9KKVVDN1A60

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument.

 

 

Identification code

Ordinary 5 pence shares

 

 

 

ISIN: GB00BK7YQK64

b)

Nature of the transaction

Acquisition of ordinary shares of 5 pence pursuant to the Enhanced Scrip Dividend Alternative.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.3176

49,117

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

£0.3176

49,117

£15,599.56

e)

Date of the transaction

10 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Notification of dealing form

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Alan Olivier

2

Reason for the notification

a)

Position/status

Alternate Director to Desmond de Beer, Non-Executive Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer

a)

Name

Hammerson plc

b)

LEI

213800G1C9KKVVDN1A60

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument.

 

 

Identification code

Ordinary 5 pence shares

 

 

 

ISIN: GB00BK7YQK64

b)

Nature of the transaction

Acquisition of ordinary shares of 5 pence pursuant to the Enhanced Scrip Dividend Alternative.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.3176

43,899

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

£0.3176

43,899

£13,942.32

e)

Date of the transaction

10 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

This announcement has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANSXFFDAEEA
Date   Source Headline
25th Feb 20197:00 amRNSDividend Declaration
25th Feb 20197:00 amRNSFinal Results
18th Feb 201911:30 amRNSHolding(s) in Company
8th Feb 20193:30 pmRNSHolding(s) in Company
7th Feb 20191:00 pmRNSDirector/PDMR Shareholding
5th Feb 20197:00 amRNSBoard Change
4th Feb 201911:00 amRNSHolding(s) in Company
1st Feb 201912:00 pmRNSTotal Voting Rights
25th Jan 20197:00 amRNSBoard Changes
22nd Jan 201911:00 amRNSDirector Declaration
21st Jan 20197:00 amRNSNotification of 2018 Full Year Results
11th Jan 20192:30 pmRNSDirector/PDMR Shareholding
2nd Jan 20191:00 pmRNSTotal Voting Rights
2nd Jan 20197:00 amRNSTransaction in Own Shares
2nd Jan 20197:00 amRNSShare buyback programme update
31st Dec 20187:00 amRNSTransaction in Own Shares
28th Dec 20187:00 amRNSTransaction in Own Shares
27th Dec 20187:00 amRNSTransaction in Own Shares
24th Dec 20187:00 amRNSHolding(s) in Company
24th Dec 20187:00 amRNSTransaction in Own Shares
21st Dec 20187:00 amRNSTransaction in Own Shares
20th Dec 20187:00 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSTransaction in Own Shares
19th Dec 20183:15 pmRNSDirector/PDMR Shareholding
19th Dec 20182:30 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSTransaction in Own Shares
17th Dec 20187:00 amRNSTransaction in Own Shares
14th Dec 20187:00 amRNSTransaction in Own Shares
13th Dec 20187:00 amRNSTransaction in Own Shares
12th Dec 20187:00 amRNSTransaction in Own Shares
11th Dec 20187:00 amRNSTransaction in Own Shares
10th Dec 201811:15 amRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSTransaction in Own Shares
7th Dec 20187:00 amRNSTransaction in Own Shares
6th Dec 20187:00 amRNSTransaction in Own Shares
5th Dec 20187:00 amRNSTransaction in Own Shares
4th Dec 20187:00 amRNSTransaction in Own Shares
3rd Dec 201811:00 amRNSTotal Voting Rights
3rd Dec 20187:00 amRNSTransaction in Own Shares
30th Nov 20182:30 pmRNSBlock listing Interim Review
30th Nov 20187:00 amRNSTransaction in Own Shares
29th Nov 20187:00 amRNSTransaction in Own Shares
29th Nov 20187:00 amRNSHammerson completes £236m Highcross sale
28th Nov 20187:00 amRNSTransaction in Own Shares
27th Nov 20187:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.